125 related articles for article (PubMed ID: 36906861)
21. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
23. Neurologic late effects associated with radiologic evidence of vertebral osteoradionecrosis after salvage laryngectomy: A syndrome associated with survivors of laryngeal and hypopharyngeal cancer.
Rosko AJ; Spector ME; Griffin GR; Vainshtein JM; Lee J; Bradford CR; Prince ME; Moyer JS; Worden FP; Eisbruch A; Chepeha DB
Head Neck; 2016 Aug; 38(8):1187-93. PubMed ID: 27080049
[TBL] [Abstract][Full Text] [Related]
24. Carbon ion reirradiation compared to intensity-modulated re-radiotherapy for recurrent head and neck cancer (CARE): a randomized controlled trial.
Held T; Lang K; Regnery S; Weusthof K; Hommertgen A; Jäkel C; Tonndorf-Martini E; Krisam J; Plinkert P; Zaoui K; Freudlsperger C; Moratin J; Krauss J; Harrabi SB; Herfarth K; Debus J; Adeberg S
Radiat Oncol; 2020 Aug; 15(1):190. PubMed ID: 32758267
[TBL] [Abstract][Full Text] [Related]
25. SPECT/CT-guided elective nodal irradiation for head and neck cancer: Estimation of clinical benefits using NTCP models.
de Veij Mestdagh PD; Janssen T; Lamers E; Carbaat C; Hamming-Vrieze O; Vogel WV; Sonke JJ; Al-Mamgani A
Radiother Oncol; 2019 Jan; 130():18-24. PubMed ID: 30087057
[TBL] [Abstract][Full Text] [Related]
26. [Prognostic factors affecting results of comprehensive treatment of hypopharyngeal carcinoma].
Xu W; Lyu Z; Yang Z; Zou J; Cao H
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jul; 49(7):533-8. PubMed ID: 25257265
[TBL] [Abstract][Full Text] [Related]
27. Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal.
Huang SH; O'Sullivan B; Su J; Ringash J; Bratman SV; Kim J; Hosni A; Bayley A; Cho J; Giuliani M; Hope A; Spreafico A; Hansen AR; Siu LL; Gilbert R; Irish JC; Goldstein D; de Almeida J; Tong L; Xu W; Waldron J
Cancer; 2020 Aug; 126(15):3426-3437. PubMed ID: 32478895
[TBL] [Abstract][Full Text] [Related]
28. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
29. Effect of preoperative immunonutrition on complications after salvage surgery in head and neck cancer.
Mueller SA; Mayer C; Bojaxhiu B; Aeberhard C; Schuetz P; Stanga Z; Giger R
J Otolaryngol Head Neck Surg; 2019 May; 48(1):25. PubMed ID: 31151486
[TBL] [Abstract][Full Text] [Related]
30. Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancer.
Yokota T; Onoe T; Ogawa H; Hamauchi S; Iida Y; Kamijo T; Suda T; Yurikusa T; Nishimura T; Yasui H; Onitsuka T
Jpn J Clin Oncol; 2015 Feb; 45(2):183-8. PubMed ID: 25420692
[TBL] [Abstract][Full Text] [Related]
31. Weekly hypofractionated radiation therapy in elderly non-resectable cutaneous squamous cell carcinoma of the head and neck region.
De Felice F; Musio D; Tombolini V
Radiol Med; 2021 Apr; 126(4):620-622. PubMed ID: 33058025
[TBL] [Abstract][Full Text] [Related]
32. Management of a glottic squamous cell carcinoma with cutaneous metastasis.
Alkan A; Kayış D; Çelik SY; Uylaş S; Demir Pektaş S; Oral Tapan Ö; Gökdoğan O; Türkkan G; Genç S; Tanrıverdi Ö
J Oncol Pharm Pract; 2020 Sep; 26(6):1495-1498. PubMed ID: 32028840
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6&7 randomised trial with accelerated radiotherapy for head and neck cancer.
Mortensen HR; Overgaard J; Specht L; Overgaard M; Johansen J; Evensen JF; Andersen LJ; Andersen E; Grau C
Radiother Oncol; 2012 Apr; 103(1):69-75. PubMed ID: 22398313
[TBL] [Abstract][Full Text] [Related]
34. Recommendations for postoperative radiotherapy in head & neck squamous cell carcinoma in the presence of flaps: A GORTEC internationally-reviewed HNCIG-endorsed consensus.
Carsuzaa F; Lapeyre M; Gregoire V; Maingon P; Beddok A; Marcy PY; Salleron J; Coutte A; Racadot S; Pointreau Y; Graff P; Beadle B; Benezery K; Biau J; Calugaru V; Castelli J; Chua M; Di Rito A; Dore M; Ghadjar P; Huguet F; Jardel P; Johansen J; Kimple R; Krengli M; Laskar S; Mcdowell L; Nichols A; Tribius S; Valduvieco I; Hu C; Liem X; Moya-Plana A; D'onofrio I; Parvathaneni U; Takiar V; Orlandi E; Psyrri A; Shenouda G; Sher D; Steuer C; Shan Sun X; Tao Y; Thomson D; Tsai MH; Vulquin N; Gorphe P; Mehanna H; Yom SS; Bourhis J; Thariat J
Radiother Oncol; 2021 Jul; 160():140-147. PubMed ID: 33984351
[TBL] [Abstract][Full Text] [Related]
35. Postoperative radiotherapy dose requirement in standard combined-modality practice for head and neck squamous cell carcinoma: Analysis of salient surgical and radiotherapy parameters in 2 cohorts.
Mohanti BK; Thakar A; Kaur J; Bahadur S; Malik M; Gandhi AK; Bhasker S; Sharma A
Head Neck; 2017 Sep; 39(9):1788-1796. PubMed ID: 28586138
[TBL] [Abstract][Full Text] [Related]
36. Clinical outcome and patterns of recurrence of head and neck squamous cell carcinoma with a limited field of postoperative radiotherapy.
Goto Y; Kodaira T; Furutani K; Tachibana H; Tomita N; Ito J; Hanai N; Ozawa T; Hirakawa H; Suzuki H; Hasegawa Y
Jpn J Clin Oncol; 2013 Jul; 43(7):719-25. PubMed ID: 23667153
[TBL] [Abstract][Full Text] [Related]
37. Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of life.
Spencer CR; Gay HA; Haughey BH; Nussenbaum B; Adkins DR; Wildes TM; DeWees TA; Lewis JS; Thorstad WL
Cancer; 2014 Dec; 120(24):3994-4002. PubMed ID: 25143048
[TBL] [Abstract][Full Text] [Related]
38. Head and neck muscle spasm after radiotherapy: management with botulinum toxin A injection.
Van Daele DJ; Finnegan EM; Rodnitzky RL; Zhen W; McCulloch TM; Hoffman HT
Arch Otolaryngol Head Neck Surg; 2002 Aug; 128(8):956-9. PubMed ID: 12162778
[TBL] [Abstract][Full Text] [Related]
39. Surgery or Radiotherapy of the Primary Tumor in T1-2 Head and Neck Squamous Cell Carcinoma with Resectable N3 Nodes: A Multicenter GETTEC Study.
Carsuzaa F; Thariat J; Gorphe P; Righini C; Cosmidis A; Thureau S; Roge M; De Mones E; Servagi-Vernat S; Tonnerre D; Morinière S; Dugas A; Malard O; Pasquier F; Vergez S; Salleron J; Dufour X
Ann Surg Oncol; 2019 Oct; 26(11):3673-3680. PubMed ID: 31264120
[TBL] [Abstract][Full Text] [Related]
40. Randomized clinical trial on reduction of radiotherapy dose to the elective neck in head and neck squamous cell carcinoma; update of the long-term tumor outcome.
Deschuymer S; Nevens D; Duprez F; Daisne JF; Dok R; Laenen A; Voordeckers M; De Neve W; Nuyts S
Radiother Oncol; 2020 Feb; 143():24-29. PubMed ID: 32044165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
